New apartment sales drop 12%

During the month of August, 970 new apartments were sold, of which 35.2% were located in the center of the country; about 32.5% were in Tel Aviv, while only 11% of the apartments sold were in Haifa and 2.5% in other northern parts of the country.

By SHARON WROBEL
November 6, 2006 07:38

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

New apartments sales between May and August this year fell 12.1 percent compared with the period between January to April due to the hostilities in the North, the Central Bureau of Statistics reported on Sunday. During the month of August 2006, 970 new apartments were sold, of which 35.2% were located in the center of the country; about 32.5% were in Tel Aviv, while only 11% of the apartments sold were in Haifa and 2.5% in other northern parts of the country.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS